FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma

Ting-Ting Cao,Di Xiang,Bei-Lei Liu,Tu-Xiong Huang,Bin-Bin Tan,Chui-Mian Zeng,Zhong-Yuan Wang,Xiao-Yan Ming,Li-Yi Zhang,Guangyi Jin,Feng Li,Jian-Lin Wu,Xin-Yuan Guan,Desheng Lu,Li Fu
DOI: https://doi.org/10.18632/oncotarget.19586
2017-07-26
Oncotarget
Abstract:Frizzled (FZD) proteins are receptors for secreted WNT proteins and play a critical role in the malignant progression of various cancers. However, the role of human FZD family members in esophageal squamous cell carcinoma (ESCC) was rarely investigated. In this study, we found that the <i>FZD7</i> gene was the most commonly up-regulated <i>FZD</i> member in ESCC cell lines compared with other <i>FZDs</i>. TMA studies further validated that FZD7 protein was up-regulated in 165 of 252 (65.5%) informative ESCC patients and significantly correlated with poor overall survival (P=0.001). Additionally, multivariate Cox regression analysis showed that FZD7 overexpression was an independent prognostic factor for ESCC patients. Ectopic expression of <i>FZD7</i> could promote ESCC cell metastasis both <i>in vitro</i> and <i>in vivo</i>. Under WNT3A stimulation, FZD7 was able to induce the nuclear translocation of β-catenin and activate the downstream targets of WNT/β-catenin signaling, as well as promote epithelial-mesenchymal transition (EMT) potential in ESCC cells. Our study demonstrated for the first time that FZD7 contributes to the malignant progression of ESCC and represents a novel prognostic marker and a potential therapeutic target for ESCC patients.
What problem does this paper attempt to address?